Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial.
Han-Byoel LeeWonshik HanSoo-Yeon KimNariya ChoKyoung-Eun KimJung Hyun ParkYoung Wook JuEun-Shin LeeSung-Joon LimJung Ho KimHan Suk RyuDae-Won LeeMiso KimTae-Yong KimKyung-Hun LeeSung Ui ShinSu Hyun LeeJung Min ChangHyeong-Gon MoonSeock-Ah ImWoo Kyung MoonIn-Ae ParkDong-Young NohPublished in: Breast cancer research and treatment (2020)
Investigation using stringent MRI criteria and ultrasound-guided biopsy could accurately predict patients with pCR after NAC. A larger prospective clinical trial evaluating the clinical safety of breast surgery omission after NAC in selected patients will be conducted based on these findings.
Keyphrases
- neoadjuvant chemotherapy
- ultrasound guided
- clinical trial
- fine needle aspiration
- locally advanced
- magnetic resonance imaging
- end stage renal disease
- transcription factor
- contrast enhanced
- lymph node
- ejection fraction
- newly diagnosed
- sentinel lymph node
- study protocol
- minimally invasive
- chronic kidney disease
- phase iii
- phase ii
- diffusion weighted imaging
- squamous cell carcinoma
- early stage
- coronary artery bypass
- atrial fibrillation
- real time pcr